Yi-gan san for the treatment of borderline personality disorder: an open-label study.
about
Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditionsYi-gan san restores behavioral alterations and a decrease of brain glutathione level in a mouse model of schizophreniaYokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study.Yokukansan promotes hippocampal neurogenesis associated with the suppression of activated microglia in Gunn rat.Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, multicenter, double-blind, placebo-controlled trial.Psychopharmacologic treatment of borderline personality disorder.Use of Yokukansan (TJ-54) in the treatment of neurological disorders: a review.Orengedoku-to augmentation in cases showing partial response to yokukan-san treatment: a case report and literature review of the evidence for use of these Kampo herbal formulae.Multiple Psychopharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan, and the Brain Regions it Affects.Mother/offspring co-administration of the traditional herbal remedy yokukansan during the nursing period influences grooming and cerebellar serotonin levels in a rat model of neurodevelopmental disorders.Analysis of the traditional medicine YiGan San by the fragmentation patterns of cadambine indole alkaloids using HPLC coupled with high-resolution MS.Geissoschizine methyl ether, an alkaloid from the Uncaria hook, improves remyelination after cuprizone-induced demyelination in medial prefrontal cortex of adult mice.Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis).Successful treatment of poststroke emotional incontinence with yokukansan, an Asian herbal medicine: report of two cases.
P2860
Q27022174-BA019482-7EB9-41EA-BF37-8896BDF44695Q30452926-C8457F58-D568-40AD-9B3D-4B1409A6E332Q34495483-4D91C5B0-6D34-44F3-B91E-83672AC940F8Q34524383-086F81F0-6D35-491C-A016-D92A9F6C1330Q35543762-D6720DB3-A6D4-4EF9-8727-140948CC2729Q37262938-29C7BED6-36DB-4568-AB69-668E41F5CC11Q37784767-BE2C752A-86D9-4E73-BFF7-A3EF4E8E4B41Q38078932-B9A3A040-6E5F-4AFF-9BF4-73BAC4F0962FQ39220519-2F0B081A-7D0C-41C4-A9D5-F7C61D25755AQ42688262-EF1CB150-E971-4FD2-B2DC-8D98D2552801Q43630731-909B7428-7007-45D6-8F96-F6063036521AQ43883661-79F66C40-FD99-453F-958C-2D85026C30DEQ44379910-B8458A51-FECA-4ADA-9404-11C41A4F70FCQ50590298-515551D4-51FF-43A2-8F8F-73B84C1A74B0
P2860
Yi-gan san for the treatment of borderline personality disorder: an open-label study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Yi-gan san for the treatment of borderline personality disorder: an open-label study.
@en
Yi-gan san for the treatment of borderline personality disorder: an open-label study.
@nl
type
label
Yi-gan san for the treatment of borderline personality disorder: an open-label study.
@en
Yi-gan san for the treatment of borderline personality disorder: an open-label study.
@nl
prefLabel
Yi-gan san for the treatment of borderline personality disorder: an open-label study.
@en
Yi-gan san for the treatment of borderline personality disorder: an open-label study.
@nl
P2093
P1476
Yi-gan san for the treatment of borderline personality disorder: an open-label study.
@en
P2093
Hideaki Yasuda
Jun Horiguchi
Maiko Hayashia
Motohide Furuya
Takuji Inagaki
Tsuyshi Miyaoka
P304
P356
10.1016/J.PNPBP.2007.07.026
P577
2007-08-08T00:00:00Z